Imugene appoints Dr John Byon as chief medical officer to lead...
Imugene Ltd has tapped Dr John Byon as chief medical officer (CMO), effective immediately, to lead the company’s clinical development strategy as it progresses its pipeline of immuno-oncology therapies. Immunotherapy expertise Byon is a physician-scientist …